Advertisement

Fasten als Therapie – Indikationen und klinische Ergebnisse

  • Eva Lischka
  • Norbert Lischka
Chapter

Zusammenfassung

In Deutschland hat das Fasten eine lange Tradition. Viele der Pioniere des therapeutischen Fastens kommen aus dem deutschsprachigen Raum. In der Medizin wurde das therapeutische Fasten lange Zeit unterschätzt und daher als nebenwirkungsfreie Maßnahme vernachlässigt. Die derzeitig vorliegenden wissenschaftlichen Daten lassen erkennen, dass therapeutisches Fasten als eine effektive und kostengünstige Alternative bei einer Vielzahl von Beschwerden öfter zur Anwendung kommen sollte. Der Wunsch der Patienten nach natürlichen Behandlungsmethoden kommt diesem Anspruch entgegen.

Literatur

  1. Ahmet I, Wan R, Mattson MP et al.: Chronic alternate-day fasting results in reduced diastolic compliance and diminished systolic reserve in rats. J Card Fail 16: 843–853 (2010)CrossRefGoogle Scholar
  2. Brandhorst S, Wei M, Hwang S, Morgan TE, Longo VD: Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression. Exp Gerontol 48: 1120–1128 (2013)CrossRefGoogle Scholar
  3. Darlington LG, Ramsey NW, Mansfield JR: Placebo- controlled, blind study of dietary manipulation therapy in rheumatoid arthritis. Lancet 1: 236–238 (1986)CrossRefGoogle Scholar
  4. Dessi-Fulgheri P, Sarzani R, Serenelli M et al.: Low calorie diet enhances renal, hemodynamic, and humoral effects of exogenous atrial natriuretic peptide in obese hypertensives. Hypertension 33: 658–662 (1999)CrossRefGoogle Scholar
  5. Goehler L, Hahnemann T, Michael N et al.: Reduction of plasma catecholamines in humans during clinically controlled severe underfeeding. Prev Med 30: 95–102 (2000)CrossRefGoogle Scholar
  6. Goldhamer AC: Initial cost of care results in medically supervised water-only fasting for treating high blood pressure and diabetes. J Altern Complement Med 8: 696–697 (2002)CrossRefGoogle Scholar
  7. Goldhamer AC, Lisle D, Parpia B, Anderson SV, Campbell TC: Medically supervised water-only fasting in the treatment of hypertension. J Manipulative Physiol Ther 24: 335–339 (2001)CrossRefGoogle Scholar
  8. Goldhamer AC, Lisle DJ, Sultana P et al.: Medically supervised water-only fasting in the treatment of borderline hypertension. J Altern Complement Med 8: 643–650 (2002)CrossRefGoogle Scholar
  9. Hafstrom I, Ringertz B, Gyllenhammar H et al.: Effects of fasting on disease activity, neutrophil function, fatty acid composition, and leukotriene biosynthesis in patients with rheumatoid arthritis. Arthritis Rheum 31: 585–592 (1988)CrossRefGoogle Scholar
  10. Hargraves WA, Hentall ID: Analgesic effects of dietary caloric restriction in adult mice. Pain 114: 455–461 (2005)CrossRefGoogle Scholar
  11. Horne BD, May HT, Anderson JL et al.: Intermountain Heart Collaborative Study: Usefulness of routine periodic fasting to lower risk of coronary artery disease in patients undergoing coronary angiography. Am J Cardiol 102: 814–819 (2008)CrossRefGoogle Scholar
  12. Hussin NM, Shahar S, Teng NI, Ngah WZ, Das SK: Efficacy of fasting and calorie restriction (FCR) on mood and depression among ageing men. J Nutr Health Aging 17: 674–680 (2013)CrossRefGoogle Scholar
  13. Kanazawa M, Fukudo S: Effects of fasting therapy on irritable bowel syndrome. Int J Behav Med 13: 214–220 (2006)CrossRefGoogle Scholar
  14. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF et al.: Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 338: 899–902 (1991)CrossRefGoogle Scholar
  15. Lee C, Longo VD: Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene 30: 3305–3316 (2011)CrossRefGoogle Scholar
  16. Lee C, Raffaghello L, Brandhorst S et al.: Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemo therapy. Sci Transl Med 4: 124ra127 (2012)CrossRefGoogle Scholar
  17. Lim EL, Hollingsworth KG, Aribisala BS et al.: Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54: 2506–2514 (2011)CrossRefGoogle Scholar
  18. Lipecki R: Klinische Studie zur Effizienz einer kombinierten Heilfastenbehandlung als Migränetherapie. Dissertation, Medizinische Fakultät der Universität Würzburg, Würzburg, S. 1–53 (1990)Google Scholar
  19. Maoz E, Shamiss A, Peleg E et al.: The role of atrial natriuretic peptide in natriuresis of fasting. J Hypertens 10: 1041–1044 (1992)CrossRefGoogle Scholar
  20. Lützner H: Stellenwert der einzelnen Therapien im Rehabilitationsplan einer Stoffwechselklinik. In: Beck M, Eissenhauer W, Löffler H (Herg.), Rehabilitation heute. Die Reha-Studie Baden. Karlsruhe: Braun, S.115–124 (1982)Google Scholar
  21. Lützner H: Erlebnisbetonte Impulse zur Veränderung des Konsumverhaltens in der diätetischen Behandlung des metabolischen Syndroms. Akt Ernähr Med 20: 232–235 (1995)Google Scholar
  22. Michalsen A: Stressed patients, stressed physicians and the need for mind-body medicine. Forsch Komplementmed 17: 237–239 (2010)CrossRefGoogle Scholar
  23. Michalsen A, Weidenhammer W, Melchart D et al.: Short-term therapeutic fasting in the treatment of chronic pain and fatigue syndromes – well-being and side effects with and without mineral supplements. Forsch Komplementarmed Klass Naturheilkd 9: 221–227 (2002)PubMedGoogle Scholar
  24. Michalsen A, Schneider S, Rodenbeck A et al.: The short-term effects of fasting on the neuroendocrine system in patients with chronic pain syndromes. Nutr Neurosci 6: 11–18 (2003)CrossRefGoogle Scholar
  25. Michalsen A, Hoffmann B, Moebus et al.: Incorporation of fasting therapy in an integrative medicine ward: evaluation of outcome, safety, and effects on lifestyle adherence in a large prospective cohort study. J Altern Complement Med 11: 601–607 (2005a)CrossRefGoogle Scholar
  26. Michalsen A, Riegert M, Ludtke et al.: Mediterranean diet or extended fasting’s influence on changing the intestinal microflora, immunoglobulin A secretion and clinical outcome in patients with rheumatoid arthritis and fibromyalgia: an observational study. BMC Complement Altern Med 5: 22 (2005b)CrossRefGoogle Scholar
  27. Michalsen A, Kuhlmann MK, Lüdtke R, et al.: Prolonged fasting in patients with chronic pain syndromes leads to late mood-enhancement not related to weight loss and fasting-induced leptin depletion. Nutr Neurosci 9: 195–200 (2006)CrossRefGoogle Scholar
  28. Michalsen A, Frey UH, Merse S, Siffert W, Dobos GJ: Hunger and mood during extended fasting are dependent on the GNB3 C825T polymorphism. Ann Nutr Metab 54: 184–188 (2009)CrossRefGoogle Scholar
  29. Michalsen A, Li C, Kaiser K, Ludtke R et al.: In-patient treatment of fibromyalgia: a controlled nonrandomized comparison of conventional medicine versus integrative medicine including fasting therapy. Evid Based Complement Alternat Med 2013: 908610 (2013)Google Scholar
  30. Müller H, Wilhelmi de Toledo F, Schuck P, Resch KL: Blutdrucksenkung durch Fasten bei adipösen und nichtadipösen Hypertonikern. Perfusion 14: 108–112 (2001a)Google Scholar
  31. Müller H, Wilhelmi de Toledo F, Resch KL: Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review. Scand J Rheumatol 30: 1–10 (2001b)Google Scholar
  32. Raffaghello L, Lee C, Safdie FM et al.: Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci USA 105: 8215–8220 (2008)CrossRefGoogle Scholar
  33. Remely M, Hippe B, Geretschlaeger I et al.: Increased gut microbiota diversity and abundance of Faecalibacterium prausnitzii and Akkermansia after fasting: a pilot study. Wien Klin Wochenschr 127: 394–398 (2015)CrossRefGoogle Scholar
  34. Roky R, Houti I, Moussamih S, Qotbi S, Aadil N: Physiological and chronobiological changes during Ramadan intermittent fasting. Ann Nutr Metab 48: 296–303 (2004)CrossRefGoogle Scholar
  35. Safdie FM, Dorff T, Quinn D et al.: Fasting and cancer treatment in humans: a case series report. Aging 1: 988–1007 (2009)CrossRefGoogle Scholar
  36. de los Santos-Arteaga M, Sierra-Dominguez SA, Fontanella GH et al.: Analgesia induced by dietary restriction is mediated by the kappa-opioid system. J Neurosci 23: 11120–11126 (2003)CrossRefGoogle Scholar
  37. Schmidt S, Stange R, Lischka E et al.: Uncontrolled clinical study of the efficacy of ambulant fasting in patients with osteoarthritis. Forsch Komplementmed 17: 87–94 (2010)CrossRefGoogle Scholar
  38. Schubmann R, Graban I, Holz G, Zwingmann C: Ergebnisqualität stationärer Rehabilitation bei Patienten mit Adipositas. Deutsche Rentenversicherung 9–10: 1–22 (1997)Google Scholar
  39. Skoldstam L, Larsson L, Lindstrom FD: Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol 8: 249–255 (1979)CrossRefGoogle Scholar
  40. Schwartz MW, Seeley RJ: Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. N Engl J Med 336: 1802–1811 (1997)CrossRefGoogle Scholar
  41. Spark RF, Arky RA, Boulter PR et al.: Renin, aldosterone and glucagon in the natriuresis of fasting. N Engl J Med 292: 1335–1340 (1975)CrossRefGoogle Scholar
  42. Stange R: Fasting therapy improves insulin resistance (HOMA-IR) in patients with the metabolic syndrome. In: Abstract: North American Research Conference on Complementary and Integrative Medicine. Edmonton, CA; 34 (2006)Google Scholar
  43. Uden AM, Trang L, Venizelos N, Palmblad J: Neutrophil functions and clinical performance after total fasting in patients with rheumatoid arthritis. Ann Rheum Dis 42: 45–51 (1983)CrossRefGoogle Scholar
  44. Varady KA, Hellerstein MK: Alternate-day fasting and chronic disease prevention: a review of human and animal trials. Am J Clin Nutr 86: 7–13 (2007)CrossRefGoogle Scholar
  45. Varela A, Marina Prendes MG, Testoni G et al.: Influence of fasting on the effects of ischemic preconditioning in the ischemic-reperfused rat heart. Arch Physiol Biochem 110: 189–196 (2002)CrossRefGoogle Scholar
  46. Watts NB, DiGirolamo M: Carbohydrate tolerance improves with fasting in obese subjects with noninsulin-dependent (type II) diabetes. Am J Med Sci 299: 250–256 (1990)CrossRefGoogle Scholar
  47. Wilhelmi de Toledo F, Buchinger A, Burggrabe H e al.: Leitlinien zur Fastentherapie. Forsch Komplementärmed Klass Naturheilkd 9: 189–198 (2002)Google Scholar
  48. Wilhelmi de Toledo F, Buchinger A, Burggrabe H et al.: Fasting therapy – an expert panel update of the 2002 consensus guidelines. Forsch Komplementärmed 20: 434–443 (2013)CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2018

Authors and Affiliations

  • Eva Lischka
    • 1
  • Norbert Lischka
    • 2
  1. 1.Klinik Buchinger am Bodensee GmbHÜberlingenDeutschland
  2. 2.Klinik Buchinger am Bodensee GmbHÜberlingenDeutschland

Personalised recommendations